FLT3 and acute myeloid leukemia: Given the importance of FLT3-ID and of the FLT3 pathway in the pathogenesis and prognosis of patients with AML, consistent efforts are in progress for the development and clinical testing of FLT3 inhibitors (reviewed in [94]).